JP2025505229A5 - - Google Patents
Info
- Publication number
- JP2025505229A5 JP2025505229A5 JP2024547302A JP2024547302A JP2025505229A5 JP 2025505229 A5 JP2025505229 A5 JP 2025505229A5 JP 2024547302 A JP2024547302 A JP 2024547302A JP 2024547302 A JP2024547302 A JP 2024547302A JP 2025505229 A5 JP2025505229 A5 JP 2025505229A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pyrrolidine
- carbonyl
- butyl
- tert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20220016377 | 2022-02-08 | ||
| KR10-2022-0016377 | 2022-02-08 | ||
| PCT/KR2023/001712 WO2023153762A1 (ko) | 2022-02-08 | 2023-02-07 | 멜라노코르틴-4 수용체 효능제의 희귀성 유전적 비만질환의 예방 또는 치료에서의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505229A JP2025505229A (ja) | 2025-02-21 |
| JP2025505229A5 true JP2025505229A5 (cg-RX-API-DMAC7.html) | 2026-02-17 |
Family
ID=87564659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547302A Pending JP2025505229A (ja) | 2022-02-08 | 2023-02-07 | 稀少遺伝性肥満症の予防または治療におけるメラノコルチン-4受容体アゴニストの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250134898A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4461297A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025505229A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230120106A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119300835A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128463A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023218785A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3248118A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024002389A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024011882A2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024009854A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI838114B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023153762A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3202315A1 (en) * | 2020-12-22 | 2022-06-30 | Hee Dong Park | Use as selective agonist of malanocortin-4 receptor |
| KR20250046623A (ko) * | 2023-09-27 | 2025-04-03 | 주식회사 엘지화학 | 멜라노코르틴-4 수용체 효능제의 pcsk1 결핍 적응증과 연관된 희귀성 유전적 비만질환의 예방 또는 치료 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI332501B (en) * | 2006-07-14 | 2010-11-01 | Lg Life Sciences Ltd | Melanocortin receptor agonists |
| US12516047B2 (en) * | 2019-11-07 | 2026-01-06 | Lg Chem, Ltd. | Melanocortin-4 receptor agonists |
| CN116507615A (zh) * | 2020-10-29 | 2023-07-28 | 株式会社Lg化学 | 黑皮质素受体激动剂化合物的晶型i及其制备方法 |
| TWI804170B (zh) * | 2021-01-21 | 2023-06-01 | 南韓商Lg化學股份有限公司 | 黑皮質素-4受體促效劑的用途 |
| TWI826938B (zh) * | 2021-02-26 | 2023-12-21 | 南韓商Lg化學股份有限公司 | 黑皮質素-4受體促效劑 |
| TWI861780B (zh) * | 2022-03-28 | 2024-11-11 | 南韓商Lg化學股份有限公司 | 預防或治療肥胖的聯合療法 |
-
2023
- 2023-02-06 TW TW112104117A patent/TWI838114B/zh active
- 2023-02-07 US US18/837,125 patent/US20250134898A1/en active Pending
- 2023-02-07 EP EP23753110.8A patent/EP4461297A4/en active Pending
- 2023-02-07 CN CN202380032193.6A patent/CN119300835A/zh active Pending
- 2023-02-07 CA CA3248118A patent/CA3248118A1/en active Pending
- 2023-02-07 JP JP2024547302A patent/JP2025505229A/ja active Pending
- 2023-02-07 KR KR1020230016160A patent/KR20230120106A/ko not_active Ceased
- 2023-02-07 AR ARP230100283A patent/AR128463A1/es unknown
- 2023-02-07 AU AU2023218785A patent/AU2023218785A1/en active Pending
- 2023-02-07 WO PCT/KR2023/001712 patent/WO2023153762A1/ko not_active Ceased
-
2024
- 2024-08-08 CL CL2024002389A patent/CL2024002389A1/es unknown
- 2024-08-12 MX MX2024009854A patent/MX2024009854A/es unknown
- 2024-08-30 CO CONC2024/0011882A patent/CO2024011882A2/es unknown